Jerome D. Goldberg

Array ( [id] => 3588159 [patent_doc_number] => 05550133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Carbamates of rapamycin' [patent_app_type] => 1 [patent_app_number] => 8/448869 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10505 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 422 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550133.pdf [firstpage_image] =>[orig_patent_app_number] => 448869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3526863 [patent_doc_number] => 05541192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Rapamycin amidino carbamates' [patent_app_type] => 1 [patent_app_number] => 8/448902 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4349 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 552 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541192.pdf [firstpage_image] =>[orig_patent_app_number] => 448902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3613602 [patent_doc_number] => 05534514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Anti-neoplastic compositions and methods for application thereof' [patent_app_type] => 1 [patent_app_number] => 8/445794 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8221 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534514.pdf [firstpage_image] =>[orig_patent_app_number] => 445794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682571 [patent_doc_number] => 05633241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => '19-nor-vitamin D compounds' [patent_app_type] => 1 [patent_app_number] => 8/442488 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4845 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 303 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633241.pdf [firstpage_image] =>[orig_patent_app_number] => 442488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695496 [patent_doc_number] => 05618805 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => '19-nor-vitamin D compounds' [patent_app_type] => 1 [patent_app_number] => 8/442483 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4836 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618805.pdf [firstpage_image] =>[orig_patent_app_number] => 442483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516260 [patent_doc_number] => 05576309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 8/440839 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14209 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576309.pdf [firstpage_image] =>[orig_patent_app_number] => 440839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326519 [patent_doc_number] => 06329361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'High-dose chromic picolinate treatment of type II diabetes' [patent_app_type] => 1 [patent_app_number] => 8/440362 [patent_app_country] => US [patent_app_date] => 1995-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2314 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329361.pdf [firstpage_image] =>[orig_patent_app_number] => 440362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3493690 [patent_doc_number] => 05561136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-01 [patent_title] => 'Method of treating cancer by conjunctive therapy with N,N\'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent' [patent_app_type] => 1 [patent_app_number] => 8/437469 [patent_app_country] => US [patent_app_date] => 1995-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4027 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/561/05561136.pdf [firstpage_image] =>[orig_patent_app_number] => 437469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008783 [patent_doc_number] => 05889007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => '10, 11-methanodibenzosuberane derivatives' [patent_app_type] => 1 [patent_app_number] => 8/436992 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9949 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889007.pdf [firstpage_image] =>[orig_patent_app_number] => 436992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510676 [patent_doc_number] => 05587402 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Regression of mammalian leukemia cell tumors' [patent_app_type] => 1 [patent_app_number] => 8/434811 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4453 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587402.pdf [firstpage_image] =>[orig_patent_app_number] => 434811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3679166 [patent_doc_number] => 05633016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Combination chemotherapy' [patent_app_type] => 1 [patent_app_number] => 8/434897 [patent_app_country] => US [patent_app_date] => 1995-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3921 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633016.pdf [firstpage_image] =>[orig_patent_app_number] => 434897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664708 [patent_doc_number] => 05668122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Method to treat cancer with tetracyclines' [patent_app_type] => 1 [patent_app_number] => 8/431751 [patent_app_country] => US [patent_app_date] => 1995-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2182 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668122.pdf [firstpage_image] =>[orig_patent_app_number] => 431751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626367 [patent_doc_number] => 05621007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Method for regulation of transmembrane chloride conductance' [patent_app_type] => 1 [patent_app_number] => 8/431695 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5423 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621007.pdf [firstpage_image] =>[orig_patent_app_number] => 431695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992371 [patent_doc_number] => 05891866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Methods of treatment' [patent_app_type] => 1 [patent_app_number] => 8/424689 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3763 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891866.pdf [firstpage_image] =>[orig_patent_app_number] => 424689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3550738 [patent_doc_number] => 05547959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements' [patent_app_type] => 1 [patent_app_number] => 8/423183 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1869 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547959.pdf [firstpage_image] =>[orig_patent_app_number] => 423183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3555762 [patent_doc_number] => 05543418 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements' [patent_app_type] => 1 [patent_app_number] => 8/423133 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1868 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543418.pdf [firstpage_image] =>[orig_patent_app_number] => 423133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657421 [patent_doc_number] => 05622963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements' [patent_app_type] => 1 [patent_app_number] => 8/423182 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1869 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622963.pdf [firstpage_image] =>[orig_patent_app_number] => 423182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3667116 [patent_doc_number] => 05599839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Antiviral composition' [patent_app_type] => 1 [patent_app_number] => 8/424558 [patent_app_country] => US [patent_app_date] => 1995-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 3969 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599839.pdf [firstpage_image] =>[orig_patent_app_number] => 424558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3634624 [patent_doc_number] => 05610200 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth' [patent_app_type] => 1 [patent_app_number] => 8/420435 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7086 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610200.pdf [firstpage_image] =>[orig_patent_app_number] => 420435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3544731 [patent_doc_number] => 05554617 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Method for treating cancer with 6-aryl pyrimidine compounds' [patent_app_type] => 1 [patent_app_number] => 8/419963 [patent_app_country] => US [patent_app_date] => 1995-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12117 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 449 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554617.pdf [firstpage_image] =>[orig_patent_app_number] => 419963 [rel_patent_id] =>[rel_patent_doc_number] =>)